Nguyen Minh Cong, Park Jong Taek, Jeon Yeong Gwan, Jeon Byeong Hwa, Hoe Kwang Lae, Kim Young Myeong, Lim Hyun Kyo, Ryoo Sungwoo
Department of Biology, College of Natural Sciences, School of Medicine, Kangwon National University, Chuncheon, Korea.
Department of Anesthesiology and Pain Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
Yonsei Med J. 2016 Nov;57(6):1329-38. doi: 10.3349/ymj.2016.57.6.1329.
Peroxynitrite plays a critical role in vascular pathophysiology by increasing arginase activity and decreasing endothelial nitric oxide synthase (eNOS) activity. Therefore, the aims of this study were to investigate whether arginase inhibition and L-arginine supplement could restore peroxynitrite-induced endothelial dysfunction and determine the involved mechanism.
Human umbilical vein endothelial cells (HUVECs) were treated with SIN-1, a peroxynitrite generator, and arginase activity, nitrite/nitrate production, and expression levels of proteins were measured. eNOS activation was evaluated via Western blot and dimer blot analysis. We also tested nitric oxide (NO) and reactive oxygen species (ROS) production and performed a vascular tension assay.
SIN-1 treatment increased arginase activity in a time- and dose-dependent manner and reciprocally decreased nitrite/nitrate production that was prevented by peroxynitrite scavenger in HUVECs. Furthermore, SIN-1 induced an increase in the expression level of arginase I and II, though not in eNOS protein. The decreased eNOS phosphorylation at Ser1177 and the increased at Thr495 by SIN-1 were restored with arginase inhibitor and L-arginine. The changed eNOS phosphorylation was consistent in the stability of eNOS dimers. SIN-1 decreased NO production and increased ROS generation in the aortic endothelium, all of which was reversed by arginase inhibitor or L-arginine. N(G)-Nitro-L-arginine methyl ester (L-NAME) prevented SIN-1-induced ROS generation. In the vascular tension assay, SIN-1 enhanced vasoconstrictor responses to U46619 and attenuated vasorelaxant responses to acetylcholine that were reversed by arginase inhibition.
These findings may explain the beneficial effect of arginase inhibition and L-arginine supplement on endothelial dysfunction under redox imbalance-dependent pathophysiological conditions.
过氧亚硝酸盐通过增加精氨酸酶活性和降低内皮型一氧化氮合酶(eNOS)活性在血管病理生理学中起关键作用。因此,本研究的目的是探讨精氨酸酶抑制和L-精氨酸补充是否能恢复过氧亚硝酸盐诱导的内皮功能障碍,并确定其中涉及的机制。
用人脐静脉内皮细胞(HUVECs)进行处理,用过氧亚硝酸盐发生器SIN-1处理,然后测量精氨酸酶活性、亚硝酸盐/硝酸盐生成量以及蛋白质表达水平。通过蛋白质印迹法和二聚体印迹分析评估eNOS激活情况。我们还检测了一氧化氮(NO)和活性氧(ROS)的生成,并进行了血管张力测定。
SIN-1处理以时间和剂量依赖性方式增加精氨酸酶活性,同时相应降低亚硝酸盐/硝酸盐生成量,而过氧亚硝酸盐清除剂可在HUVECs中阻止这种降低。此外,SIN-1诱导精氨酸酶I和II的表达水平升高,但eNOS蛋白水平未升高。精氨酸酶抑制剂和L-精氨酸可恢复SIN-1导致的Ser1177位点eNOS磷酸化降低以及Thr495位点磷酸化增加。eNOS磷酸化的变化与eNOS二聚体的稳定性一致。SIN-1降低主动脉内皮中的NO生成并增加ROS生成,而精氨酸酶抑制剂或L-精氨酸均可逆转这些变化。N(G)-硝基-L-精氨酸甲酯(L-NAME)可阻止SIN-1诱导的ROS生成。在血管张力测定中,SIN-1增强了对U46619的血管收缩反应,并减弱了对乙酰胆碱的血管舒张反应,而精氨酸酶抑制可逆转这些反应。
这些发现可能解释了在氧化还原失衡依赖性病理生理条件下,精氨酸酶抑制和L-精氨酸补充对内皮功能障碍的有益作用。